Navigation Links
Linhardt to discuss drug safety and the impacts of globalization on pharmaceutical manufacturing
Date:2/1/2011

Troy, N.Y. Robert J. Linhardt will discuss drug safety in an increasingly global economy during the 2011 AAAS Annual Meeting in Washington, D.C.

Linhardt, the Ann and John H. Broadbent Jr. '59 Senior Constellation Professor of Biocatalysis and Metabolic Engineering at Rensselaer, will present on how to maintain a safe drug supply on Saturday, Feb. 19, from 8 to 9 a.m. in room 147B of the Washington Convention Center, during the symposium titled "Medicine Safety in a World of Science Without Borders."

Linhardt, who was named in 2009 as one the Scientific American 10 for his lifesaving work, is among the world's foremost experts on the commonly used blood thinner heparin. His research has helped make the currently available heparin safer for patients and is leading the effort to create a safer, fully synthetic alternative to the current heparin, which is harvested from the intestines of mostly foreign livestock. During the symposium, he will discuss this research and lessons that he learned when people around the world died after taking what were thought to be routine dosages of heparin.

Following the deaths of patients around the world from a dosage of heparin in early 2008, scientists scrambled to find the cause. In April 2008, Linhardt and a small team of scientists announced the source of the patient death and illness a complex carbohydrate named oversulfated chondroitin sulfate. It was a contaminant so structurally similar to heparin it was nearly undetectable to some of the most advanced technology available.

Linhardt and Jian Liu at the University of North Carolina discovered the "recipe" for synthetic heparin five years ago. Today, Linhardt and his team have prepared a purer, safer alternative creating the first fully synthetic heparin, and the largest amount ever created in the laboratory.

Linhardt will be joined in the discussion by fellow heparin experts Zachary Shriver of the Massachusetts Institute of Technology and Ali Al-Hakim of the U.S. Food and Drug Administration.


'/>"/>

Contact: Gabrielle DeMarco
demarg@rpi.edu
518-276-6542
Rensselaer Polytechnic Institute
Source:Eurekalert

Related medicine news :

1. mHealth Alliance Works in Partnership with GSMA to Expand Discussion of Mobile Health at 2010 Mobile World Congress
2. NAMI Encourages DSM-5 Discussion
3. WellPoint To Hold Conference Call and Webcast To Discuss 2010 Financial Outlook on March 17, 2010
4. The Future of Cosmetic Dermatology: Leading Dermatologist Dr. David Goldberg Discusses the Latest Facial Rejuvenation Techniques
5. David Anderson to discuss what model organisms can teach us about emotion
6. International Merchant Advisors CEO Mel Roseman to Discuss New Medical Marijuana Clinics Live on CBS Radio Networks Big Biz Show February 22, 2010 at 1:40 pm PST
7. NAE, IOM members to discuss engineering innovations in health care at Feb. 25 meeting
8. AFL-CIO President Richard Trumka to Discuss TSA Bargaining Rights on Inside Government Radio Show
9. Six "Common Sense" Points Not Included In The Health Care Discussion? Should They Be?
10. Six "Common Sense" Points Not Included In The Health Care Discussion? Should They Be?
11. Improvements needed in genomic test result discussions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... MD (PRWEB) , ... March 29, 2017 , ... ... is proud to announce the finalization of the company’s executive management team with prominent ... and leading operations is Curio Wellness’ Chief Operating Officer, Ted Dumbauld , who ...
(Date:3/29/2017)... Linda, Ca (PRWEB) , ... March 29, 2017 , ... ... of a growing number of cancers and is touted to be the next revolution ... treatment, thus far, has been in the form of immune checkpoint inhibitors such as ...
(Date:3/29/2017)... ... 29, 2017 , ... The Wharton School of the University of Pennsylvania is ... made a $10 million gift to establish the Ken Moelis and Julie Taffet ... to a Wharton MBA for highly-qualified Penn undergraduates whose academic and career interests expand ...
(Date:3/28/2017)... CA (PRWEB) , ... March 28, 2017 , ... Tuesday, ... asking the American public to take the Diabetes Risk Test to find out if ... the Los Angeles World Airports will light up the evening sky by programming the ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, ... be invited to the Siemens Healthineers annual customer education symposium, a world-class learning ... take place from March 27 - 31, 2017 at the Atlanta Marriott Marquis ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Research and Markets has announced the addition of the ... to their offering. ... The ablation device global market is expected to grow at ... Ablation is the minimally invasive therapeutic tissue excision procedure ... tissue removal, to the removal of abnormally conducting cardiac tissue in ...
(Date:3/29/2017)...   Royal Philips (NYSE: PHG, AEX: ... PathAI, a company that develops artificial intelligence technology ... develop solutions that improve the precision and accuracy ... The partnership aims to build deep learning applications ... intelligence to be applied to massive pathology data ...
(Date:3/29/2017)... , March 29, 2017 On March 28, the U.S. ... adult patients with relapsing forms of multiple sclerosis (MS) ... first drug approved by the FDA for PPMS. Ocrevus ... professional.  "Multiple sclerosis can have a ... Dunn , M.D., director of the Division of Neurology ...
Breaking Medicine Technology: